Literature DB >> 17503402

Detection of recombinant human erythropoietin in urine for doping analysis: interpretation of isoelectric profiles by discriminant analysis.

Françoise Lasne1, Jean Thioulouse, Laurent Martin, Jacques de Ceaurriz.   

Abstract

The detection in urine of recombinant human erythropoietin (rHuEPO), a hormone misused by endurance athletes as a doping agent, is based on the differentiation of its isoelectric pattern from that of the corresponding natural hormone. Different empirical criteria have been proposed for discriminating the images of the patterns but none of them have been elaborated from a rational statistical approach. Discriminant analysis was applied to a dataset of profiles defined as positive (116 profiles from 26 subjects) (presence of rHuEPO and possibly residual natural endogenous hormone) and negative (131 profiles from 131 subjects) (presence of natural endogenous hormone only). The different bands were numbered according to a template of 16 possible positions and their relative intensities constituted the 16 variables of the statistical analysis. This method was then tested with data from an administration trial of low doses (6.7-10 IU/kg) following high-dose (265 IU/kg) injections (71 profiles from one subject). The analysis of the dataset clearly separated the negative and positive profiles. A cross-validation procedure confirmed that the analysis was extremely stable: with ten-fold cross-validation, no false positives were observed even with 100,000 simulations. Furthermore, the detection of rHuEPO in the profiles from the low-dose trial was greatly improved in comparison with a previously validated empirical criterion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17503402     DOI: 10.1002/elps.200600363

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  5 in total

Review 1.  From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports?

Authors:  Giuseppe Fischetto; Stéphane Bermon
Journal:  Sports Med       Date:  2013-10       Impact factor: 11.136

Review 2.  Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.

Authors:  S Elliott
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

Review 3.  Erythropoietin and cancer: the unintended consequences of anemia correction.

Authors:  Nataša Debeljak; Peter Solár; Arthur J Sytkowski
Journal:  Front Immunol       Date:  2014-11-11       Impact factor: 7.561

4.  Sensitivity and specificity of detection methods for erythropoietin doping in cyclists.

Authors:  Jules A A C Heuberger; Peter van Eenoo; Joris I Rotmans; Pim Gal; Frederik E Stuurman; Titiaan E Post; Johannes M A Daniels; Herman Ram; Olivier de Hon; Jacobus Burggraaf; Adam F Cohen
Journal:  Drug Test Anal       Date:  2019-07-17       Impact factor: 3.345

5.  Effects of Angiotensin II on Erythropoietin Production in the Kidney and Liver.

Authors:  Yukiko Yasuoka; Yuichiro Izumi; Takashi Fukuyama; Hideki Inoue; Tomomi Oshima; Taiga Yamazaki; Takayuki Uematsu; Noritada Kobayashi; Yoshitaka Shimada; Yasushi Nagaba; Masashi Mukoyama; Yuichi Sato; Jeff M Sands; Katsumasa Kawahara; Hiroshi Nonoguchi
Journal:  Molecules       Date:  2021-09-05       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.